G1 Therapeutics News

G1 Therapeutics | 8-K: Current report

Jun 14 16:30 ET

G1 Therapeutics | 8-K: Current report

May 1 06:44 ET

G1 Therapeutics | DEF 14A: Definitive information statements

Apr 25 16:18 ET

G1 Therapeutics | DEFA14A: Others

Apr 25 16:17 ET

G1 Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Apr 12 16:14 ET

G1 Therapeutics | 8-K: Current report

Mar 22 16:19 ET

G1 Therapeutics | 8-K: Current report

Feb 28 06:37 ET

G1 Therapeutics | 8-K: Current report

Feb 12 16:25 ET

G1 Therapeutics | 8-K: Current report

Jan 8 00:00 ET

G1 Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Nov 1, 2023 16:37 ET

G1 Therapeutics | 8-K: Current report

Nov 1, 2023 06:46 ET

G1 Therapeutics | 8-K: Current report

Sep 21, 2023 16:15 ET

G1 Therapeutics | 8-K: Current report

Aug 2, 2023 06:50 ET

G1 Therapeutics | 8-K: Current report

Jun 16, 2023 16:03 ET

G1 Therapeutics | 8-K: Current report

Jun 9, 2023 16:34 ET

G1 Therapeutics | 8-K: G1 Therapeutics Provides First Quarter 2023 Financial Results and Operational Highlights

May 3, 2023 06:46 ET

G1 Therapeutics | DEFA14A: Others

Apr 26, 2023 16:07 ET

G1 Therapeutics | DEF 14A: Definitive proxy statements

Apr 26, 2023 16:05 ET

G1 Therapeutics | 8-K: Current report

Mar 10, 2023 16:18 ET

G1 Therapeutics | 8-K: Current report

Mar 1, 2023 06:37 ET